La cadena de opciones muestra datos clave de las opciones de acciones de Sensei Biotherapeutics a varios precios de ejercicio y fechas de vencimiento. Los operadores utilizan esta información para analizar posibles operaciones y evaluar el sentimiento del mercado para Sensei Biotherapeutics..

Sensei Biotherapeutics (NASDAQ:SNSE) Bolsa, Cadena de Opciones

SENSEI BIOTHERAPEUTICS INC

Sensei Biotherapeutics

Sensei Biotherapeutics Inc is an immuno-oncology company focused on the discovery and development of next-generation therapeutics for cancer patients. Its TMAb (Tumor Microenvironment Activated Biologics) platform developing selective therapeutics designed to disable immunosuppressive signals or activate immunostimulatory signals selectively in the tumor microenvironment. The company have four investigational product candidates in various stages of development: SNS-101 (VISTA), SNS-102 (VSIG4 ), SNS-103 (ENTPDase/CD39), SNS-201 (VISTAxCD28).

Sensei Biotherapeutics, Inc. - Common Stock

Sensei Biotherapeutics Inc

CyberArk Software Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CYBR#NASDAQ">CYBR</a>) will release earnings results for the first quarter, before the <a href="https://www.benzinga.com/quote/CYBR/earnings">opening bell on Tuesday, May 13.</a>
Analysts expect the Petah Tikva, Israel-based company to report quarterly earnings at 79 cents per share, up from 75 cents per share in the year-ago period. CyberArk Software projects to report quarterly revenue at $305.58 million, compared to $221.55 million a year earlier, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
On Feb. 13, CyberArk Software reported fiscal fourth-quarter revenue growth of 41% year-on-year to $314.40 million, beating the analyst consensus estimate of $301.31 million.
CyberArk Software shares gained 2.3% to close at $367.66 on Monday.
Benzinga readers can access the latest analyst ratings on the <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">Analyst Stock Ratings</a> page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.
Let's have a look at how Benzinga's most-accurate <a href="https://www.benzinga.com/quote/CYBR/analyst-ratings">analysts have rated the company</a> in the recent period.
<ul class="wp-block-list">
<li>Cantor Fitzgerald analyst Jonathan Ruykhaver reiterated an Overweight rating with a price target of $400 on April 24, 2025. This analyst has an accuracy rate of 72%.</li>
<li>Roth Capital analyst Taz Koujalgi initiated coverage on the stock with a Buy rating and a price target of $415 on April 23, 2025. This analyst has an accuracy rate of 81%.</li>
<li>Morgan Stanley analyst Hamza Fodderwala maintained an Equal-Weight rating and cut the price target from $390 to $380 on April 16, 2025. This analyst has an accuracy rate of 77%.</li>
<li>Barclays analyst Saket Kalia maintained an Overweight rating and slashed the price target from $450 to $405 on April 14, 2025. This analyst has an accuracy rate of 78%.</li>
<li>RBC Capital analyst Matthew Hedberg reiterated an Outperform rating with a price target of $420 on April 11, 2025. This analyst has an accuracy rate of 73%.</li>
</ul>
Considering buying CYBR stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="593" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/13033337/image-133-1024x593.png" alt="" class="wp-image-913011" style="width:672px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/13033337/image-133-1024x593.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/13033337/image-133-300x174.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/13033337/image-133-768x444.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/13033337/image-133.png 1111w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/trading-ideas/short-ideas/25/05/45347009/top-2-tech-stocks-that-may-crash-in-q2">Top 2 Tech Stocks That May Crash In Q2</a> </li>
</ul>
Photo via Shutterstock

Earnings

News

Price Target

Pre-Market Outlook

Markets

Analyst Ratings

Trading Ideas

CYBR

CyberArk Software Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

The Federal Trade Commission has accused Amazon.com Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>) of concealing key evidence in the antitrust case that claims the <a href="https://www.benzinga.com/government/regulations/25/01/42822625/big-techs-date-with-antitrust-alphabet-meta-amazon-brace-for-legal-showdowns-in-2025">retail giant abused its market power</a>. As per a new court filing, the FTC says Amazon withheld thousands of non-privileged documents by incorrectly labeling them as protected.
What Happened: Following an order by a federal judge to re-review its privilege claims, Amazon withdrew 92% of them and presented around 70,000 documents it had withheld earlier, according <a href="https://www.courthousenews.com/ftc-accuses-amazon-of-hiding-evidence-in-antitrust-case/">to</a> the Courthouse News Service. 
The FTC discovered that around 75% of those had been completely shielded from view. In a small in-camera review, a single sentence out of nine documents was deemed privileged. 
One document quoted a top executive calling founder and former CEO Jeff Bezos Amazon's "chief dark arts officer" when describing the "shady world" of tactics employed to boost Prime subscriptions, the report noted.
See Also: <a href="https://www.benzinga.com/government/regulations/25/05/45331065/the-trade-desk-ceo-slams-google-amazons-walled-gardens-imagine-what-we-can-do-in-a-fair-market">The Trade Desk CEO Slams Google, Amazon&#8217;s &#8216;Walled Gardens&#8217;: &#8216;Imagine What We Can Do In A Fair Market&#8217;</a>
Why It Matters: The FTC says these documents were withheld not because they were legally protected, but because they &nbsp;damaging evidence. "In essence, Amazon's privilege log — on which the FTC has relied throughout discovery — was almost entirely wrong," the commission wrote in its motion. "It is impossible to square a 92% error rate across tens of thousands of documents with a mere mistake."
The commission also said that Amazon has a pattern of falsely labeling routine communications as "privileged" and alleged that the company instructs staff to mislabel documents to sidestep regulatory scrutiny. "The blatant nature and ubiquity of these actions demonstrate&#8230; a purposeful plan," the FTC added.
Calling the withheld records &#8220;probative, inculpatory, and entirely nonprivileged,&#8221; the FTC has asked the court for another 90 days of discovery and for Amazon to bear the resulting costs. Amazon denies any wrongdoing. "The FTC wants to distract from the facts," a spokesperson said in a statement.
Amazon is not the only tech giant locking horns with the FTC. Last month, hearings began as part of the FTC's <a href="https://www.benzinga.com/news/25/04/44888906/meta-faces-an-antitrust-lawsuit-ftc-says-company-holds-a-social-network-monopoly">antitrust lawsuit against Meta</a>.
Amid these high-profile cases, the FTC is also facing a shortage of resources due <a href="https://www.benzinga.com/government/regulations/25/03/44310724/doge-cuts-to-ftc-sow-confusion-in-case-against-amazon">to cuts enacted by DOGE</a>.
Image Via Shutterstock
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/analyst-ratings/price-target/25/05/45356821/why-amazons-robot-army-could-save-10-billion-and-change-your-delivery-game">Why Amazon&#8217;s Robot Army Could Save $10 Billion And Change Your Delivery Game</a></li>
</ul>

Equities

Legal

Tech

General

AMZN

Jeff Bezos Called 'Chief Dark Arts Officer' In Secret Amazon Doc As FTC Says Company Hid Thousands Of Key Files In Antitrust Case

LSEA

Reported Earlier, New Home Co. Announced A Definitive Agreement To Acquire Landsea Homes Corporation For $11.30 Per Share In An All-cash Transaction That Represents An Enterprise Value Of Approximately $1.2B

ARK Invest CEO Cathie Wood applauded Coinbase Global Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COIN#NASDAQ">COIN</a>) on its inclusion in the S&amp;P 500 index, marking the first cryptocurrency <a href="https://www.benzinga.com/markets/cryptocurrency/25/05/45365186/coinbase-stock-jumps-nearly-11-after-hours-monday-heres-why">company to achieve this milestone</a>.
What Happened: Wood responded to Coinbase CEO Brian Armstrong&#8216;s announcement by congratulating both him and the company on X, calling the recognition &#8220;well deserved.&#8221; 
She noted that while active managers like ARK Invest rely on fundamental research rather than index providers to select stocks, the inclusion of Coinbase in a major index would force index-tracking funds to take notice. &#8220;Index-sensitive managers will be compelled to consider COIN now,&#8221; Wood wrote. 
The S&amp;P 500 addition represents a watershed moment for cryptocurrency legitimacy in traditional finance, potentially forcing index fund managers to allocate capital to the digital asset space. 
Armstrong highlighted this achievement as validation that &#8220;crypto is here to stay,&#8221; reflecting growing mainstream acceptance of the asset class despite its historically volatile nature.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Well deserved recognition, <a href="https://twitter.com/brian_armstrong?ref_src=twsrc%5Etfw">@brian_armstrong</a> and <a href="https://twitter.com/coinbase?ref_src=twsrc%5Etfw">@coinbase</a>! While you probably agree that active managers should depend on fundamental research, not index providers, to screen for stocks, <a href="https://twitter.com/ARKInvest?ref_src=twsrc%5Etfw">@ARKInvest</a> is pleased that index-sensitive managers will be compelled to consider <a href="https://twitter.com/search?q=%24COIN&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$COIN</a> now. <a href="https://t.co/STfHZJ8wAw">https://t.co/STfHZJ8wAw</a>
&mdash; Cathie Wood (@CathieDWood) <a href="https://twitter.com/CathieDWood/status/1922109018710913516?ref_src=twsrc%5Etfw">May 13, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
See Also: <a href="https://www.benzinga.com/government/regulations/25/05/45367206/sp-500-rallies-over-3-on-us-china-90-day-tariff-truce-but-experts-warn-it-doesnt-guarantee-a-complete-resolution-of-the-trade-war">S&amp;P 500 Rallies Over 3% On US-China 90-Day Tariff Truce, But Experts Warn It &#8216;Doesn&#8217;t Guarantee A Complete Resolution Of The Trade War&#8217;</a>
Why It Matters: Wood has maintained an exceptionally bullish outlook on cryptocurrency markets, recently reiterating ARK&#8217;s forecast of Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) reaching between <a href="https://www.benzinga.com/markets/cryptocurrency/25/05/45335755/cathie-wood-stands-firm-on-bold-700000-bitcoin-prediction-for-investors-says-bull-case-in-the-1-5-million-range">$700,000 and $750,000 by 2030</a> in her base case, with a bull case target of $1.5 million. 
She attributes this dramatic growth potential to Bitcoin&#8217;s capacity to capture market share from gold, increasing institutional adoption and emerging market applications. 
This S&amp;P 500 inclusion comes amid Coinbase&#8217;s aggressive expansion efforts, including its recent <a href="https://www.benzinga.com/markets/cryptocurrency/25/05/45287050/coinbase-acquires-deribit-in-2-9b-deal-to-expand-crypto-derivatives-business">$2.9 billion acquisition of crypto</a> options exchange Deribit and the launch of 24/7 trading for Bitcoin and Ethereum (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>) futures through its Commodity Futures Trading Commission -regulated exchange, making it the first regulated <a href="https://www.benzinga.com/markets/cryptocurrency/25/05/45324908/coinbase-launches-24-7-bitcoin-ethereum-futures-trading-what-does-that-mean">U.S. exchange to offer around-the-clock access</a> to leveraged crypto derivatives.
Image Via Shutterstock
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/equities/25/05/45366492/jim-cramer-says-sit-tight-as-china-tariff-pause-creates-game-of-chicken-that-could-steamroll-market-timers">Jim Cramer Says &#8216;Sit Tight&#8217; As China Tariff Pause Creates &#8216;Game Of Chicken&#8217; That Could Steamroll Market Timers</a></li>
</ul>
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Fintech news covering the emerging Financial Technology services sector

Fintech

Macro Economic Events

Politics

Economics

$BTC

$ETH

COIN

Cathie Wood Says 'Index-Sensitive Managers Will Be Compelled to Consider' Coinbase As Crypto Exchange Platform Joins S&P 500 Index

JD.com, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JD#NASDAQ">JD</a>) will release earnings results for the first quarter, before the opening <a href="https://www.benzinga.com/quote/JD/earnings">bell on Tuesday, May 13</a>.
Analysts expect the China-based company to report quarterly earnings at $1.02 per share. JD.com projects to report quarterly revenue at $37.91 billion, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
On April 17, JD.com filed its annual report on Form 20-F for the fiscal year ended Dec. 31, 2024.
JD.com shares gained 6.5% to close at $36.05 on Monday.
Benzinga readers can access the latest analyst ratings on the <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">Analyst Stock Ratings</a> page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.
Let's have a look at how Benzinga's most-accurate <a href="https://www.benzinga.com/quote/GBX/analyst-ratings">analysts have rated the company</a> in the recent period.
<ul class="wp-block-list">
<li>Susquehanna analyst Shyam Patil maintained a Neutral rating and raised the price target from $35 to $45 on March 12, 2025. This analyst has an accuracy rate of 68%.</li>
<li>Mizuho analyst James Lee maintained an Outperform rating and increased the price target from $43 to $50 on March 7, 2025. This analyst has an accuracy rate of 78%.</li>
<li>Benchmark analyst Fawne Jiang maintained a Buy rating and raised the price target from $47 to $58 on March 7, 2025. This analyst has an accuracy rate of 69%.</li>
<li>Barclays analyst Gregory Zhao maintained an Overweight rating and boosted the price target from $50 to $55 on Feb. 28, 2025. This analyst has an accuracy rate of 70%.</li>
<li>Loop Capital analyst Rob Sanderson upgraded the stock from Hold to Buy and cut the price target from $49 to $48 on Oct. 21, 2024. This analyst has an accuracy rate of 66%.</li>
</ul>
Considering buying JD stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="586" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/13030538/image-131-1024x586.png" alt="" class="wp-image-912969" style="width:570px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/13030538/image-131-1024x586.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/13030538/image-131-300x172.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/13030538/image-131-768x440.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/13030538/image-131.png 1148w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/trading-ideas/short-ideas/25/05/45347009/top-2-tech-stocks-that-may-crash-in-q2">Top 2 Tech Stocks That May Crash In Q2</a> </li>
</ul>
Photo via Shutterstock

JD.com Gears Up For Q1 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts

Board of Directors authorized a new share repurchase program with the total amount up to NT$525 million (approximately US$16.4 million, based on the exchange rate of NT$31.96 to US$1.00 as of April 30, 2025).
Under the program, the company will repurchase up to 15 million shares from the open market on the Taiwan Stock Exchange, approximately 2.06% of its issued share capital. The shares will be repurchased within a price range of NT$18.87 to NT$35.00 per share, while the buyback will still be carried out if the stock price falls lower than the aforementioned range. The authorization repurchase program period is from May 14 to July 13, 2025.

Buybacks

IMOS

ChipMOS Announces NT$525M ($16.4M) Share Repurchase Program Covering Up To 15M Shares

ChipMOS TECHNOLOGIES (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IMOS#NASDAQ">IMOS</a>) reported quarterly earnings of $0.15 per share. This is a 58.33 percent decrease over earnings of $0.36 per share from the same period last year. The company reported $166.70 million in sales this quarter. This is a 2.08 percent increase over sales of $163.30 million the same period last year.

ChipMOS TECHNOLOGIES Q1 EPADS $0.15 Down From $0.36 YoY, Sales $166.70M Up From $163.30M YoY

Telefonica Brasil (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VIV#NYSE">VIV</a>) reported quarterly earnings of $0.11 per share. This is a 0.91 percent increase over earnings of $0.11 per share from the same period last year. The company reported $2.46 billion in sales this quarter. This is a 10.22 percent decrease over sales of $2.74 billion the same period last year.

Telefonica Brasil Q1 EPS $0.11 Up From $0.11 YoY, Sales $2.46B Down From $2.74B YoY

Renowned independent investment strategist Ed Yardeni, the President of Yardeni Research, has lowered his U.S. recession probability while raising his S&amp;P 500 target following the trade deal with China.
What Happened: After the U.S. and China announced a <a href="https://www.benzinga.com/markets/equities/25/05/45341884/apple-amazon-nvidia-rise-in-monday-premarket-as-us-china-agree-to-90-day-tariff-truce-neither-side-wants-a-decoupling">90-day truce </a>on Monday, the markets cheered the development as the S&amp;P 500 and Nasdaq 100 rallied over 3%.
While this provides a short-term relief, Yardeni noted in his QuickTakes that the negative wealth effect of President Donald Trump&#8217;s tariffs was &#8220;probably insignificant&#8221; after the announcement of the deal.
According to his earlier analysis, the tariff turmoil was having a &#8220;negative wealth effect on consumers, especially retired and soon-to-be retiring Baby Boomers, who collectively own about $25 trillion in corporate equities and mutual funds.&#8221;
This led him to raise the &#8220;subjective probability of a recession&#8221; this year from 20% to 35% on March 5, and from 35% to 45% on March 31 as stock prices tanked in response to the tariffs.
However, he said that &#8220;We didn&#8217;t cross over to the dark side subsequently, i.e., forecasting greater than a 50% chance of a recession. Instead, we lowered our recession odds back down to 35% on May 4. Now we are lowering it again to 25%.&#8221;
After Monday&#8217;s stock market rally, he also raised the S&amp;P 500 year-end target back up to 6,500 from 6,000.
See Also: <a href="https://www.benzinga.com/government/regulations/25/05/45367206/sp-500-rallies-over-3-on-us-china-90-day-tariff-truce-but-experts-warn-it-doesnt-guarantee">S&amp;P 500 Rallies Over 3% On US-China 90-Day Tariff Truce, But Experts Warn It &#8216;Doesn&#8217;t Guarantee A Complete Resolution Of The Trade War&#8217;</a>
Why It Matters: Concerning other metrics, Yardeni highlighted that he has raised the real GDP growth range to 1.5%-2.5% this year, up from our previous 0.5%-1.5%.
Also, he predicts the S&amp;P 500 forward earnings to rise to $300 per share at the end of this year.
&#8220;We now see the S&amp;P 500 forward P/E at 21.6 at the end of the year rather than 20.0 as we previously had projected,&#8221; he said.
Price Action: The SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) and Invesco QQQ Trust ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>), which track the S&amp;P 500 index and Nasdaq 100 index, respectively, jumped with joy on Monday. The SPY was up 3.30% to $582.99, while the QQQ advanced 4.07% to $507.85, according to <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a> data.
Here&#8217;s how the benchmark indices performed on Monday. 
<figure class="wp-block-table is-style-stripes"> 
<table class="has-fixed-layout">
<tbody>
<tr>
<td>Index</td>
<td>Performance (+/-)</td>
<td>Value</td>
</tr>
<tr>
<td>Nasdaq Composite</td>
<td>4.35%</td>
<td>18,708.34</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>3.26%</td>
<td>5,844.19</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>2.81%</td>
<td>42,410.10</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>3.42%</td>
<td>2,092.20</td>
</tr>
</tbody>
</table>
</figure>
After Monday, all the indices were out of the correction zone. The S&amp;P 500 index was down 4.93% from its record high of 6,147.43 points, scaled on Feb. 19. Dow Jones was 5.91% lower than its 52-week high of 45,073.63 points, and Nasdaq 100 was 6.09% lower than its previous high of 22,222.61 points.
On Tuesday, the futures of the Dow Jones, S&amp;P 500, and Nasdaq 100 indices were trading lower.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/government/regulations/25/05/45344120/cathie-wood-says-ai-innovation-in-healthcare-will-be-more-profound-than-autonomous-taxi-networks-humanoid-robots" target="_blank" rel="noreferrer noopener">Cathie Wood Says AI Innovation In Healthcare Will Be More ‘Profound' Than Autonomous Taxi Networks, Humanoid Robots</a></li>
</ul>
Image Via Shutterstock

Analyst Color

Government

Macro Notification

Market Summary

Regulations

Broad U.S. Equity ETFs

Futures

ETFs

Ed Yardeni Slashes Recession Odds To 25% After US Stocks Rally, Lifts S&P 500 Year-End Target To 6,500

Reported Earlier, First Industrial Realty Trust Prices $450M Of 5.25% Senior Notes Due 2031

Landsea Homes (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LSEA#NASDAQ">LSEA</a>) reported quarterly losses of $(0.05) per share which beat the analyst consensus estimate of $(0.09) by 44.44 percent. This is a 183.33 percent decrease over earnings of $0.06 per share from the same period last year. The company reported quarterly sales of $310.81 million which missed the analyst consensus estimate of $312.00 million by 0.38 percent. This is a 5.70 percent increase over sales of $294.04 million the same period last year.

Earnings Beats

Earnings Misses

Landsea Homes Q1 Adj. EPS $(0.05) Beats $(0.09) Estimate, Sales $310.81M Miss $312.00M Estimate

SAND

Reported Earlier, Sandstorm Responds To ISS Opposition By Simplifying Stock Option And Restricted Share Plan Proposals Ahead Of May 30 Meeting

Reported Earlier, Alliant Energy Prices $500M 3.250% Convertible Senior Notes Due 2028 In Private Placement

Former hedge fund manager Martin Shkreli took aim at the quantum computing industry again on Monday, posting a series of critical remarks on X.
 What Happened: Shkreli, widely known as &#8220;Pharma Bro&#8221; for his controversial role in the pharmaceutical industry, dismissed the commercial promise of quantum computing as being several decades away, while also accusing publicly traded quantum firms of inflating their financial narratives to mislead investors.
See Also: <a href="https://www.benzinga.com/25/05/45367075/apple-reportedly-leans-on-ai-to-solve-iphone-battery-woes-in-ios-19-update-ahead-of-thinner-iphone-17-launch-this-fall">Apple Reportedly Leans On AI To Boost iPhone Battery Life In iOS 19 Ahead Of Launching Thinner iPhone 17 This Fall</a>
&#8220;[The] Global Risk Institute interviewed 24 quantum computing experts who agreed it's 20-30 years before we see RSA2048 broken. 20-30 years before quantum works. I say 50,&#8221; Shkreli says, referencing the widely used encryption standard often cited as a benchmark for quantum disruption, along with a chart shared by the Global Risk Institute.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Global Risk Institute interviewed 24 quantum computing experts who agreed its 20-30 years before we see RSA2048 broken. 20-30 years before quantum works. i say 50. <a href="https://t.co/4X2KY20819">pic.twitter.com/4X2KY20819</a>
&mdash; Martin Shkreli (@MartinShkreli) <a href="https://twitter.com/MartinShkreli/status/1921900983652622650?ref_src=twsrc%5Etfw">May 12, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
In a follow-up Tweet, Shkreli took on several publicly traded quantum computing stocks, starting with Rigetti Computing Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RGTI#NASDAQ">RGTI</a>), which announced its <a href="https://benzinga.com/news/earnings/25/05/45360620/rigetti-stock-sinks-after-q1-revenues-miss-estimates-details">first quarter results</a> on Monday, posting a 51.77% year-over-year decline in revenues. &#8220;This is the real state of affairs in quantum compute,&#8221; he says, &#8220;nothing is happening.&#8221;
In the same post, he attacked others such as IONQ Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IONQ#NYSE">IONQ</a>), which he says is &#8220;making up&#8221; revenues via &#8220;desperate acquisitions. Followed by D-Wave Quantum Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/QBTS#NYSE">QBTS</a>) and Quantum Computing Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QUBT#NASDAQ">QUBT</a>), which he accuses of getting lucky and selling a single machine, or generating revenue via &#8220;alleged fraud.&#8221; 
Benzinga reached out to IONQ, D-Wave Quantum, Rigetti, and Quantum Computing, and is awaiting their response.
<figure class="wp-block-embed aligncenter is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true"><a href="https://twitter.com/search?q=%24RGTI&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$RGTI</a> revenue -50% y/y. This is the real state of affairs in quantum compute &#8212; nothing is happening. Companies like <a href="https://twitter.com/search?q=%24IONQ&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$IONQ</a> are making up revenue via desperate acquisitions, or through alleged fraud <a href="https://twitter.com/search?q=%24QUBT&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$QUBT</a> or just getting lucky selling a single machine and having no bookings <a href="https://twitter.com/search?q=%24QBTS&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$QBTS</a>
&mdash; Martin Shkreli (@MartinShkreli) <a href="https://twitter.com/MartinShkreli/status/1922022351509594174?ref_src=twsrc%5Etfw">May 12, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Why It Matters: Early this year, Shkreli published a comprehensive short thesis on quantum computing stocks on his X account, forecasting over 90% downsides for several stocks. The stocks covered in the thesis have witnessed a pullback since then.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true"><a href="https://t.co/mFn7V4mLaW">https://t.co/mFn7V4mLaW</a>
&mdash; Martin Shkreli (@MartinShkreli) <a href="https://twitter.com/MartinShkreli/status/1876950624824177127?ref_src=twsrc%5Etfw">January 8, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
He followed up on this a few weeks later by <a href="https://www.benzinga.com/markets/equities/25/01/43119243/martin-shkreli-calls-ionq-and-rigetti-best-shorts-despite-recent-stock-gains-cites-offline-quantum-systems">calling IonQ and Rigetti</a> the &#8220;best shorts of his career,&#8221; saying that &#8220;we are further away from quantum than even I thought.&#8221; 
More recently, Shkreli slammed Microsoft Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>) for its quantum chip breakthrough, Majorna 1. He added that the term &#8220;breakthrough&#8221; should be <a href="https://benzinga.com/25/02/43840954/pharma-bro-martin-shkreli-slams-microsofts-quantum-breakthrough-predicts-ionq-and-rgti-will-plummet-as-tech-falls-behind">used with caution</a>.
Following a strong performance in 2024, most quantum computing stocks have witnessed steep declines year-to-date in 2025, with D-Wave Quantum being the sole exception.
<figure class="wp-block-table"> 
<table class="has-fixed-layout">
<tbody>
<tr>
<td class="has-text-align-center" data-align="center">Stock / ETF</td>
<td class="has-text-align-center" data-align="center">Year-To-Date Returns</td>
<td class="has-text-align-center" data-align="center">All Time High (+/-)</td>
</tr>
<tr>
<td class="has-text-align-center" data-align="center">Rigetti Computing Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RGTI#NASDAQ">RGTI</a>)</td>
<td class="has-text-align-center" data-align="center">-42.25%</td>
<td class="has-text-align-center" data-align="center">-46.02%</td>
</tr>
<tr>
<td class="has-text-align-center" data-align="center">IONQ Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IONQ#NYSE">IONQ</a>)</td>
<td class="has-text-align-center" data-align="center">-23.69%</td>
<td class="has-text-align-center" data-align="center">-39.91%</td>
</tr>
<tr>
<td class="has-text-align-center" data-align="center">D-Wave Quantum Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/QBTS#NYSE">QBTS</a>)</td>
<td class="has-text-align-center" data-align="center">+11.55%</td>
<td class="has-text-align-center" data-align="center">-10.29%</td>
</tr>
<tr>
<td class="has-text-align-center" data-align="center">Quantum Computing Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QUBT#NASDAQ">QUBT</a>)</td>
<td class="has-text-align-center" data-align="center">-51.49%</td>
<td class="has-text-align-center" data-align="center">-98.18%</td>
</tr>
<tr>
<td class="has-text-align-center" data-align="center">Defiance Quantum ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QTUM#NASDAQ">QTUM</a>)</td>
<td class="has-text-align-center" data-align="center">+0.74%</td>
<td class="has-text-align-center" data-align="center">-8.51%</td>
</tr>
</tbody>
</table>
</figure>
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="136" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/13020038/Screenshot-2025-05-13-at-11.30.26-AM-1024x136.png" alt="" class="wp-image-912874" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/13020038/Screenshot-2025-05-13-at-11.30.26-AM-1024x136.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/13020038/Screenshot-2025-05-13-at-11.30.26-AM-300x40.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/13020038/Screenshot-2025-05-13-at-11.30.26-AM-768x102.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/13020038/Screenshot-2025-05-13-at-11.30.26-AM-1536x205.png 1536w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/13020038/Screenshot-2025-05-13-at-11.30.26-AM.png 1606w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Rigetti Computing shows strong momentum according to Benzinga Edge Stock Rankings, but how does it compare with IONQ, D-Wave, and Quantum Computing? Sign up for <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound">Benzinga Edge</a> to find out.
Photo Courtesy: Bartlomiej K. Wroblewski On Shutterstock.com
Read More: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/equities/25/05/45366492/jim-cramer-says-sit-tight-as-china-tariff-pause-creates-game-of-chicken-that-could-steamroll-market-timers">Jim Cramer Says &#8216;Sit Tight&#8217; As China Tariff Pause Creates &#8216;Game Of Chicken&#8217; That Could Steamroll Market Timers</a></li>
</ul>

IONQ

MSFT

QBTS

QTUM

QUBT

RGTI

'Pharma Bro' Martin Shkreli Rips Into Quantum Stocks: 'Nothing Is Happening'—Accuses IONQ, D-Wave Quantum, And Others Of Revenue Gimmicks

Reported Earlier, Ameren Prices Offering Of 5.55M Common Shares At $94 Each, Includes Forward Sale Agreements With Major Banks

Economist and market commentator&nbsp;Peter Schiff&nbsp;projected Monday that the next Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) pullback would trigger an unrealized loss for Michael Saylor-led Strategy Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSTR#NASDAQ">MSTR</a>) on its BTC purchases.
What Happened: During his YouTube podcast, Schiff weighed in on Bitcoin recapturing the crucial $100,000 level and Strategy buying billions in the cryptocurrency funded by debt.
&#8220;His average cost now is almost 70,000 a bitcoin, so it&#8217;s getting higher and higher,&#8221; he said.
Schiff predicted that Strategy&#8217;s average acquisition cost might reach $70,000 by his next purchase, and the subsequent Bitcoin decline could push the firm &#8220;into&nbsp;the red&#8221; for the first&nbsp;time. &#8220;We&#8217;ll see what kind of fireworks that sparks,&#8221; he added.
Strategy didn&#8217;t immediately respond to Benzinga&#8217;s request for comment.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Live podcast today at 8pm EST<a href="https://t.co/2Eub4R1DW9">https://t.co/2Eub4R1DW9</a>
&mdash; Peter Schiff (@PeterSchiff) <a href="https://twitter.com/PeterSchiff/status/1922063483249492238?ref_src=twsrc%5Etfw">May 12, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
See Also:&nbsp;<a href="https://benzinga.com/25/04/45091619/paypal-says-its-moving-quickly-on-crypto-stablecoinfintech-giant-partners-with-coinbase-to-boost-pyusd" target="_blank" rel="noreferrer noopener">PayPal CEO Says &#8216;Moving Quickly&#8217; To Bring Crypto, Stablecoin Benefits To Users — Fintech Giant Partners With Coinbase To Boost Solana-based PYUSD</a>
Why It Matters:&nbsp;Saylor&#8217;s company Strategy, formerly MicroStrategy, has been heavily investing in Bitcoin. The firm reported acquiring <a href="https://www.benzinga.com/markets/cryptocurrency/25/05/45349057/strategy-buys-134b-in-bitcoin-at-99856-cites-155-btc-yield">13,390 BTC for approximately $1.34 billion at an average price of $99,856</a> per coin on Monday, pushing their total Bitcoin holdings to 568,840 BTC, accumulated at a combined cost of $39.41 billion and an average purchase price of $69,287.
Notably, the Bitcoin treasury company <a href="https://www.benzinga.com/25/04/44704504/michael-saylor-still-trusts-bitcoins-long-term-potential-even-as-strategy-risks-going-into-losses-on-btc-buys">came close to experiencing an unrealized loss</a> on its investments last month after the apex cryptocurrency slipped below $75,000 following President Donald Trump&#8217;s sweeping tariff announcement.
Schiff, a fierce critic of all things Bitcoin, has <a href="https://www.benzinga.com/24/11/42237876/peter-schiff-predicts-microstrategys-bankruptcy-due-to-bitcoin-investment-strategy">consistently questioned Strategy&#8217;s Bitcoin playbook</a>, arguing that its commitment to repay a large sum of money to <a href="https://www.benzinga.com/markets/equities/24/11/42186167/michael-saylors-microstrategy-convertible-notes-to-buy-bitcoin-offer-no-interest-so-why-are-investors-rushing-to-buy-them" target="_blank" rel="noreferrer noopener">debt holders</a>&nbsp;could be at risk if the leading cryptocurrency falls sharply.
Price Action:&nbsp; At the time of writing, Bitcoin was exchanging hands at $102,656.68, down 1.24% in the last 24 hours, according to&nbsp;<a href="https://pro.benzinga.com/dashboard?_gl=1&#x2A;380nj0&#x2A;_ga&#x2A;MTEyOTAyOTcxMy4xNzEzMzY0NTYy&#x2A;_ga_V7ZK73W7N0&#x2A;MTcxNDk4MzIzMi42LjEuMTcxNDk4OTE0Ni4wLjAuMA.." target="_blank" rel="noreferrer noopener">data from Benzinga Pro</a>.
Shares of Strategy rose 1.02% in after-hours trading after closing 2.67% lower at $404.91 during Monday&#8217;s regular session. Year-to-date, the stock has gained nearly 80%.
MSTR demonstrated a high momentum score of 98.45 as of this writing. Visit&nbsp;<a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound" target="_blank" rel="noreferrer noopener">Benzinga Edge Stock Rankings</a> to select similar high-momentum stocks for your portfolio.
<figure class="wp-block-image size-full"><img loading="lazy" decoding="async" width="502" height="190" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/13013012/Screenshot-2025-05-13-105959.png" alt="" class="wp-image-912837" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/13013012/Screenshot-2025-05-13-105959.png 502w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/13013012/Screenshot-2025-05-13-105959-300x114.png 300w" sizes="(max-width: 502px) 100vw, 502px" /></figure>
Photo Courtesy: Wirestock Creators on Shutterstock.com
Read Next:&nbsp;
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/05/45339772/michael-saylor-harnesses-ai-to-drive-home-an-important-message-on-bitcoin-its-going-up-forever">Michael Saylor Harnesses AI To Drive Home An Important Message On Bitcoin: &#8216;It&#8217;s Going Up Forever&#8217;</a></li>
</ul>

MSTR

Peter Schiff Predicts 'Fireworks,' Says Michael Saylor's Strategy Will See Unrealized Loss During Bitcoin's Next Bearish Dip

PACK

Ranpak Partners With Thalia To Deliver Large-Scale Sustainable Packaging Automation Across 500+ Stores And Ecommerce Network

ORCL

Oracle Expands Defense Ecosystem With seQure Partnership To Offer Advanced Security Across Public And Sovereign Cloud Regions

Nouriel Roubini, the Iranian-American economist known as &#8220;Dr. Doom&#8221; for predicting the 2008 financial crisis, said that President Donald Trump &#8220;blinked and chickened out&#8221; in his trade confrontation with Chinese President Xi Jinping.
What Happened: In his recent X post, Roubini asserted that Trump received &#8220;almost no concessions from the Chinese side&#8221; in what he characterized as a decisive victory for Xi. The economist warned that continued escalation would have triggered severe economic consequences.
&#8220;The tit for tat trade war escalation started by the U.S. would have spiked U.S. inflation, led to massive supply chain disruptions and would have triggered a serious U.S. and global recession,&#8221; Roubini wrote, adding this outcome &#8220;would have doomed the GOP and the MAGA grand goals by the 2026 mid term elections.&#8221;
Roubini indicated modest Chinese concessions might emerge during the announced 90-day negotiation period to &#8220;reset&#8221; trade relations, but maintained that &#8220;so far Xi is the clear winner.&#8221;
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">As I predicted in the game of chicken between Trump and Xi it was Trump to blink and chicken out. The tit for tat trade war escalation started by the US would have spiked US inflation, led to massive supply chain disruptions and would have triggered a serious US and global…
&mdash; Nouriel Roubini (@Nouriel) <a href="https://twitter.com/Nouriel/status/1922006232958959960?ref_src=twsrc%5Etfw">May 12, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
See Also: <a href="https://www.benzinga.com/markets/cryptocurrency/25/05/45367052/trump-memecoin-exclusive-dinner-guest-list-revealed-with-justin-sun-shining-at-the-top-report">Trump Memecoin Exclusive Dinner Guest List Revealed With Justin Sun Shining At The Top: Report</a>
Why It Matters: On Monday, <a href="https://www.benzinga.com/government/regulations/25/05/45367206/sp-500-rallies-over-3-on-us-china-90-day-tariff-truce-but-experts-warn-it-doesnt-guarantee-a-complete-resolution-of-the-trade-war">the U.S. and China agreed to drastically roll back tariffs</a> for an initial 90-day period. U.S. tariffs on Chinese goods dropped from 145% to 30%, while China cut its tariffs on American goods from 125% to 10%.
The economist&#8217;s assessment comes amid his shifting economic outlook. Despite his traditional pessimism, Roubini recently expressed optimism about U.S. economic prospects, citing <a href="https://www.benzinga.com/markets/25/04/44754363/dr-doom-transforms-to-dr-boom-nouriel-roubini-says-mickey-mouse-could-be-us-president-and-economy-will-keep-growing">AI advancements potentially driving growth </a>to &#8220;4% by decade&#8217;s end&#8221; and &#8220;6% by the end of next decade.&#8221;
This analysis follows earlier warnings from Roubini that markets were <a href="https://www.benzinga.com/markets/25/04/44754363/dr-doom-transforms-to-dr-boom-nouriel-roubini-says-mickey-mouse-could-be-us-president-and-economy-will-keep-growing">&#8220;delusional&#8221; about Federal Reserve intervention</a> amid trade tensions. He previously described the situation as a &#8220;three-way game of chicken&#8221; between Trump, Fed Chair Jerome Powell, and Jinping, predicting Trump would likely concede first.
While critical of Trump&#8217;s trade policies as &#8220;crazy and unfair,&#8221; Roubini acknowledged that China &#8220;needs to reform its economic model,&#8221; noting global consensus on this point beyond just U.S. demands.
Image Via Shutterstock
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/25/05/45367075/apple-reportedly-leans-on-ai-to-solve-iphone-battery-woes-in-ios-19-update-ahead-of-thinner-iphone-17-launch-this-fall">Apple Reportedly Leans On AI To Boost iPhone Battery Life In iOS 19 Ahead Of Launching Thinner iPhone 17 This Fall</a></li>
</ul>
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Federal Reserve

'Dr. Doom' Nouriel Roubini Says Trump 'Chickened Out' In Trade War With China, Calls Xi Jinping 'The Clear Winner' After Tariff Rollback

NDAQ

SET And Nasdaq Deepen Strategic Collaboration To Align Thailand's Capital Markets With Global Standards And AI-Driven Innovation

Health Care

Press Releases

Sensei Biotherapeutics to Present Preclinical Data on SNS-103 at the CRI-ENCI Eighth International Immunotherapy Conference

Sensei Biotherapeutics to Present at Two Upcoming Scientific Conferences

Sensei Biotherapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights

Sensei Biotherapeutics to Participate in Citi's 2024 Global Healthcare Conference

Sensei Biotherapeutics Provides Corporate Update and Highlights Key Upcoming Milestones

Sensei Biotherapeutics to Participate in Oppenheimer's 35th Annual Healthcare Life Sciences Conference

Sensei Biotherapeutics Reports Favorable Preliminary Dose Expansion Data for Solnerstotug in PD-(L)1 Resistant Tumors

Sensei Biotherapeutics Reports Full Year 2024 Financial Results and Update on Clinical Progress

Sensei Biotherapeutics to Participate in the Canaccord Genuity Horizons in Oncology Virtual Conference

Sensei Biotherapeutics Reports First Quarter 2025 Financial Results and Updates on Clinical Progress

Comments

Sensei Biotherapeutics

Sensei Biotherapeutics (SNSE) Opciones

No option chain data available. Please try again later

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL